FDA Approves New Drug Trikafta for Maximum Commonplace Type of Cystic Fibrosis

0
49



TUESDAY, Oct. 22, 2019 — A brand new drug to regard maximum cystic fibrosis sufferers has been licensed by way of the U.S. Meals and Drug Management.
Trikafta (elexacaftor/ivacaftor/tezacaftor) is the primary triple aggregate treatment to be had to regard sufferers…



<

LEAVE A REPLY

Please enter your comment!
Please enter your name here